Stay updated on A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Virogen Biotechnology Inc. was added as sponsor and Angimmune LLC was removed as a collaborator. The study record revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.3%
    Check dated 2026-05-16T10:27:01.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s site revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:40:01.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:14:59.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 implemented. - Previous revision: v3.4.3 removed. - No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-20T00:22:17.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No substantive content changes observed.
    Difference
    0.1%
    Check dated 2026-03-12T20:39:38.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed on the page, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:17:35.000Z thumbnail image

Stay in the know with updates to A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.